Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimer's Disease

NCT04748861 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT04748861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04748861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimer's Disease
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 20, 2021
Completion date
December 31, 2026
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exercise intervention, high intensity exercise, normal cognition